{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:19:21Z","timestamp":1783088361905,"version":"3.54.6"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2024ZD0520002"],"award-info":[{"award-number":["2024ZD0520002"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303196"],"award-info":[{"award-number":["82303196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302913"],"award-info":[{"award-number":["82302913"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.lungcan.2026.109458","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:14:55Z","timestamp":1778825695000},"page":"109458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["OX40+ regulatory T cells suppress neoadjuvant chemotherapy response in NSCLC and reversed by combination of PD-1 blockade therapy"],"prefix":"10.1016","volume":"217","author":[{"given":"Jiali","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5880-2812","authenticated-orcid":false,"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4754-3056","authenticated-orcid":false,"given":"Yulong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiubao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8977-9214","authenticated-orcid":false,"given":"Zhenzhen","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lungcan.2026.109458_b0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109458_b0010","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/s41467-020-17046-2","article-title":"Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients","volume":"11","author":"N\u00fa\u00f1ez","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109458_b0015","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","article-title":"Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing","volume":"24","author":"Guo","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2026.109458_b0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fimmu.2019.00533","article-title":"Regulatory T cells and plasmacytoid dendritic cells within the tumor microenvironment in gastric cancer are correlated with gastric microbiota dysbiosis: a preliminary study","volume":"10","author":"Ling","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109458_b0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"issue":"20","key":"10.1016\/j.lungcan.2026.109458_b0030","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1073\/pnas.1822001116","article-title":"PD-1(+) regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer","volume":"116","author":"Kamada","year":"2019","journal-title":"PNAS"},{"issue":"7","key":"10.1016\/j.lungcan.2026.109458_b0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41419-022-05057-4","article-title":"Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC)","volume":"13","author":"Hui","year":"2022","journal-title":"Cell Death Dis."},{"issue":"16","key":"10.1016\/j.lungcan.2026.109458_b0040","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1158\/1078-0432.CCR-15-2614","article-title":"OX40+ regulatory T cells in cutaneous squamous cell carcinoma suppress effector T-cell responses and associate with metastatic potential","volume":"22","author":"Lai","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109458_b0045","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41467-021-21043-4","article-title":"Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109458_b0050","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12026-021-09211-6","article-title":"Recent advances in the role of Th17\/Treg cells in tumor immunity and tumor therapy","volume":"69","author":"Qianmei","year":"2021","journal-title":"Immunol. Res."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109458_b0055","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","article-title":"When worlds collide: Th17 and Treg cells in cancer and autoimmunity","volume":"15","author":"Knochelmann","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"7735","key":"10.1016\/j.lungcan.2026.109458_b0060","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","article-title":"Lineage tracking reveals dynamic relationships of T cells in colorectal cancer","volume":"564","author":"Zhang","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.lungcan.2026.109458_b0065","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jtho.2020.01.005","article-title":"IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy","volume":"15","author":"Travis","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109458_b0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12967-023-04187-3","article-title":"IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8\u2009+\u2009T-cell tumour infiltration","volume":"21","author":"Feng","year":"2023","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109458_b0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41419-022-04882-x","article-title":"CD4(+) T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"30","key":"10.1016\/j.lungcan.2026.109458_b0080","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau2042","article-title":"The TNFRSF members CD27 and OX40 coordinately limit T(H)17 differentiation in regulatory T cells","volume":"3","author":"Remedios","year":"2018","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109458_b0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/cmi.2018.8","article-title":"Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation","volume":"16","author":"Kumar","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109458_b0090","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.apsb.2019.08.010","article-title":"Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity","volume":"10","author":"Fu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109458_b0095","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.immuni.2016.05.013","article-title":"The costimulatory receptor OX40 inhibits interleukin-17 expression through activation of repressive chromatin remodeling pathways","volume":"44","author":"Xiao","year":"2016","journal-title":"Immunity"},{"issue":"Suppl 3","key":"10.1016\/j.lungcan.2026.109458_b0100","first-page":"A1182","article-title":"OX40-ADC, a potential new class of cancer immunotherapy by depleting Treg within TME","volume":"13","author":"Yang","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.lungcan.2026.109458_b0105","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011638","article-title":"Dual targeting OX40 and IL-2 receptor enhances antitumor activity through tumor-infiltrating Treg depletion and CD8(+) T-cell proliferation","volume":"13","author":"Cao","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109458_b0110","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1172\/JCI64859","article-title":"Depleting tumor-specific Tregs at a single site eradicates disseminated tumors","volume":"123","author":"Marabelle","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"87","key":"10.1016\/j.lungcan.2026.109458_b0115","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adg1487","article-title":"Lung tumor-infiltrating T(reg) have divergent transcriptional profiles and function linked to checkpoint blockade response","volume":"8","author":"Dykema","year":"2023","journal-title":"Sci. Immunol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226005192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226005192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:20:56Z","timestamp":1783084856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226005192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":23,"alternative-id":["S0169500226005192"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109458","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OX40+ regulatory T cells suppress neoadjuvant chemotherapy response in NSCLC and reversed by combination of PD-1 blockade therapy","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109458"}}